Profile
Jane Buus Laursen is currently Director at Stayble Therapeutics AB since 2018.
Formerly, Corporate VP-Global Business Development at Novo Nordisk A. Education includes doctorates from the University of Kansas and the Technical University of Denmark.
Jane Buus Laursen active positions
| Companies | Position | Start |
|---|---|---|
| STAYBLE THERAPEUTICS AB | Director/Board Member | 2017-12-31 |
| CAMURUS AB | Corporate Officer/Principal | 2026-03-22 |
Former positions of Jane Buus Laursen
| Companies | Position | End |
|---|---|---|
| NOVO NORDISK A/S | Corporate Officer/Principal | - |
Training of Jane Buus Laursen
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Novo Nordisk A/S
Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
University of Kansas
University of Kansas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Technical University of Denmark
Technical University of Denmark Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Camurus AB
Camurus AB Pharmaceuticals: MajorHealth Technology Provides nanoscale drug delivery systems for development of high value therapeutics | Health Technology |
Stayble Therapeutics AB
Stayble Therapeutics AB Pharmaceuticals: MajorHealth Technology Operates as a clinical stage company which develops drugs to treat disco genic chronic low back pain | Health Technology |
- Stock Market
- Insiders
- Jane Buus Laursen
















